DSP Healthcare Fund - Direct Plan - Growth

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF740KA1LG1

NAV · 02-Jul-2026

₹48.7230

+7.72%

+11.92%

1Y (CAGR)

+12.76%

3Y (CAGR)

+24.08%

5Y (CAGR)

+16.00%

Since inception (CAGR)

+23.15%

NAV history

hover for values

Risk & SIP analytics

Q1 · TOP · 3Y in category

Volatility (3y)

12.79%

Downside dev (3y)

9.26%

Max drawdown (3y)

-16.1%

Sharpe (3y)

1.37

SIP XIRR (3y)

+16.46%

SIP XIRR (5y)

+19.53%

Calendar-year returns

2020 +80.0%2021 +25.1%2022 -6.5%2023 +36.8%2024 +42.6%2025 -4.5%

Fund facts

Fund managerChirag Dagli

AUM₹33,091 Cr

Expense ratio0.51% · 2026-05-31

TER · AMFI officialDirect 0.65% · Regular 1.97% (2026-06-30)

Launch date12-Nov-2018

Plan typeOpen Ended · Equity

Min lumpsum₹100

Min SIP₹100

Lock-inNone

Volatility14.46

AMCDSP Asset Managers Private Limited

Objective · The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.

scheme documents ↗